California Supreme Court Overturns Ruling That Challenged Legality of State Cannabis Regulations

Upholding California’s law making cannabis legal, the California Supreme Court has depublished a California Court of Appeal decision in JCCrandall v. County of Santa Barbara, so that it has no effect as precedent.

The California Supreme Court’s action eliminates the Court of Appeal’s suggestion that California’s cannabis regulations were unlawful due to cannabis being unpermitted on the federal level.

“We are pleased the Court agreed to address that Court of Appeal decision at the Department of Cannabis Controls’ request, supporting California law and its legal cannabis industry,” said DCC Director Nicole Elliott.
Continue reading

New York Cannabis Control Board Approves 101 Adult-Use Licenses, Bringing Total to Date to 1,614

At the New York State Cannabis Control Board’s (CCB) monthly public meeting today, the group approved over 100 new adult-use cannabis licenses.

According to the CCB, this signals the near completion of the November licensing queue review, saying “This achievement reflects the state’s ongoing efforts to expand access to the regulated market, support small businesses, and create economic opportunities across diverse communities.”

The 101 new license approvals brings the total to 1,614, including 255 CAURD licenses, 55% of which are held by Social and Economic Equity (SEE) licensees.

Continue reading

Aurora Cannabis Unveils Groundbreaking Genetic Breakthrough for Powdery Mildew-Resistant Marijuana

Aurora Cannabis Inc., a Canadian-based global medical cannabis company, announced today the Company’s discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa.

The development of this proprietary genetic marker technology, which is now in use in Aurora’s breeding program, is set to produce powdery mildew resistant cultivars that will be explored for commercial launch this year.

“This discovery offers a critical solution to a pressing challenge in the cannabis industry worldwide. At Aurora Coast, our state-of-the-art research and development facility, we continuously search for ways to add value to our proprietary cannabis cultivars, and this discovery will lead to new means of managing disease in cannabis production. This success story underscores the impact of our investment in scientific excellence, a commitment that sets Aurora apart from our competitors,” says Lana Culley, Vice President of Innovation and International Operations at Aurora.
Continue reading

Study: Medical Cannabis Improves Outcomes for Patients With Hypermobility-Associated Chronic Pain

A study published in the American College of Rheumatology’s journal Open Rheumatology found that medical marijuana may help alleviate chronic pain in patients with hypermobility spectrum disorder (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS).

Researchers from Imperial College London analyzed data from 161 patients enrolled in the UK Medical Cannabis Registry. Over an 18-month period, participants reported significant improvements in pain-related measures, including the Short-Form McGill Pain Questionnaire 2, pain visual analog scale, and Brief Pain Inventory (P < 0.001).

Additional benefits were observed in sleep quality, anxiety levels, and overall health-related quality of life.
Continue reading

Study: CBD May Counteract Negative Effects of High-Calorie Diet, Improve Insulin Regulation

According to a new study published in the journal Biomedicine & Pharmacotherapy, CBD oil may help counteract the negative effects of a high-calorie diet by influencing insulin and glucagon regulation in pancreatic islets.

Researchers from Boston University, the University of South Dakota, and Syracuse University examined the impact of CBD on Wistar rats subjected to a hypercaloric diet. The study divided the rats into four groups, with some receiving CBD oil at a dose of 21 mg/kg orally three times per week. After 20 weeks, the researchers assessed metabolic changes, glucose tolerance, and gene expression related to insulin regulation.

CBD treatment led to reduced body weight and food intake while increasing fluid consumption. In control rats, CBD altered the expression of genes associated with insulin and glucagon production without affecting blood glucose or insulin levels. In rats on a high-calorie diet, CBD reduced glycemia and insulinemia, decreased pancreatic islet size, and influenced the expression of key genes, including those for insulin, glucagon, and the GPR55 receptor.
Continue reading

Maine Lawmakers File Bicameral and Bipartisan Bill to Remove Marijuana Conviction Ban for Health Workers

A bipartisan and bicameral coalition of 10 Maine lawmakers has introduced legislation to remove certain employment barriers for individuals with past marijuana convictions.

Filed today, the bill is led by Senator Rachel Talbot Ross (D) and State Representative David Boyer (D), with co-sponsorship from both Democrats and Republicans in the Maine Senate and House of Representatives. The measure would amend state law by removing aggravated cultivating of marijuana as a disqualifying offense for employment as a direct access worker in personal care agencies.

Under current law, individuals convicted of certain drug-related crimes—including the cultivation of marijuana under aggravated circumstances—are barred from working in roles that provide direct care to vulnerable populations. If enacted, this legislation would lift that restriction, aligning employment policies with Maine’s broader marijuana reform efforts.
Continue reading

Minnesota Senate Committee Approves Bill Allowing Tribal Medical Marijuana Patients to Buy from State-Licensed Dispensaries

Today, the Minnesota Senate Commerce and Consumer Protection Committee approved a measure to allow tribal medical marijuana patients to purchase from state-licensed dispensaries while strengthening protections for medical cannabis users.

The bill, sponsored by State Senator Scott Dibble (D), would allow patients enrolled in tribal medical cannabis programs to purchase marijuana from licensed dispensaries across the state. It also allows registered caregivers to cultivate cannabis on behalf of medical marijuana patients if the patient assigns them that right. The measure has been advanced to the Health and Human Services Committee.

Under the proposed changes, businesses with a medical marijuana retail endorsement would be authorized to distribute medical cannabis to tribal patients, provided they verify enrollment in a recognized tribal program. Additionally, the bill clarifies that individuals on parole or supervised release cannot face sanctions solely for participating in a state or tribal medical cannabis program.
Continue reading

Maryland: $1.87 Billion in Legal Marijuana Sold So Far in Fiscal Year 2025

Maryland’s marijuana industry recorded $88,037,944 in total sales for February 2025, bringing the total for FY 2025 to above $1.8 billion, according to newly released data from the Maryland Cannabis Administration.

Of that total, adult-use sales accounted for $66 million, while medical marijuana sales made up the remaining $22 million. The total figure is nearly identical to the $89 million sold in February 2024.

The average price per gram in February remained at $9. Dried marijuana flower led sales, generating $50 million in revenue, followed by concentrates at $26.5 million and edibles at $10.5 million. The remaining sales were classified under the “other” category.
Continue reading

The Most Popular Medical Cannabis Strains Right Now

From chronic pain and nausea, to anxiety and depression, medical marijuana patients use cannabis for a wide variety of ailments, with certain strains standing out among the rest due to the consistent and effective relief they provide.

GMO Cookies (aka Garlic Cookies).

While preferences can vary by condition and region, a few standout strains are dominating dispensary menus and patient demand right now across the United States. With that in mind, here are 10 of the most popular medical marijuana strains currently trending, based on data from state regulatory agencies, the strain review site Leafly, and opinions provided by out readers.

Continue reading

Hawaii Senate Committees Approve Proposal to Allow Medical Marijuana for Any Condition, Enable Certifications Via Telehealth

Hawaii’s Senate Health and Human Services and Commerce and Consumer Protection committees approved an amended version of House Bill 302 today, advancing a measure that would expand access to medical marijuana in the state.

The bill, introduced in January with eight sponsors, would allow doctors and advanced practice registered nurses (APRNs) to certify patients for medical marijuana use via telehealth rather than requiring an in-person visit. Lawmakers also amended the measure to eliminate the state’s list of qualifying conditions, allowing healthcare providers to recommend medical marijuana for any condition they deem necessary.

Currently, Hawaii law limits medical marijuana eligibility to patients diagnosed with a specific set of conditions, including cancer, epilepsy, multiple sclerosis, PTSD, severe pain, and glaucoma, among others. If enacted, HB 302 would remove these restrictions, giving doctors greater discretion in determining who can benefit from medical marijuana treatment.
Continue reading